0001354488-15-005385.txt : 20151207 0001354488-15-005385.hdr.sgml : 20151207 20151207074152 ACCESSION NUMBER: 0001354488-15-005385 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151204 FILED AS OF DATE: 20151207 DATE AS OF CHANGE: 20151207 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Midatech Pharma US Inc. CENTRAL INDEX KEY: 0000919745 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043216862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8601 SIX FORKS ROAD SUITE 160 CITY: RALEIGH STATE: NC ZIP: 27615 BUSINESS PHONE: (816) 914-7027 MAIL ADDRESS: STREET 1: 8601 SIX FORKS ROAD SUITE 160 CITY: RALEIGH STATE: NC ZIP: 27615 FORMER COMPANY: FORMER CONFORMED NAME: DARA BioSciences, Inc. DATE OF NAME CHANGE: 20080225 FORMER COMPANY: FORMER CONFORMED NAME: DARA BIOSCIENCES INC DATE OF NAME CHANGE: 20080211 FORMER COMPANY: FORMER CONFORMED NAME: POINT THERAPEUTICS INC DATE OF NAME CHANGE: 20020328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tousley David L. CENTRAL INDEX KEY: 0001436567 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23776 FILM NUMBER: 151271267 MAIL ADDRESS: STREET 1: 14610 PAWNEE LANE CITY: LEAWOOD STATE: KS ZIP: 66224 4 1 issuerdirect_section16.xml PRIMARY DOCUMENT X0306 4 2015-12-04 1 0000919745 Midatech Pharma US Inc. DARA 0001436567 Tousley David L. 8601 SIX FORKS ROAD SUITE 160 RALEIGH NC 27615 1 CFO Stock Option 4.90 2015-12-04 2015-12-04 4 D 0 35000 D 2015-12-04 2023-03-01 Common Stock 35000 0 D Stock Option 2.90 2015-12-04 2015-12-04 4 D 0 40000 D 2015-12-04 2024-03-04 Common Stock 40000 0 D Stock Option .79 2015-12-04 2015-12-04 4 D 0 97000 D 2015-12-04 2025-02-09 Common Stock 97000 0 D Stock Option .69 2015-12-04 2015-12-04 4 D 0 35000 D 2019-05-19 2025-05-19 Common Stock 35000 0 D In connection with the closing of the Agreement and Plan of Merger among DARA BioSciences, Inc. (DARA), Midatech Pharma PLC (Midatech) and certain other parties thereto, these options were assumed by Midatech and replaced with options to purchase 0.136 Midatech American Depository Receipts (Midatech ADRs) for each DARA option held, at an exercise price equal to the exercise price of the applicable DARA option divided by 0.136. Each Midatech ADR represents two Midatech ordinary shares. /s/ David L. Tousley 2015-12-07